FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were ...

As interest on cash savings becomes increasingly less attractive, Paul Summers has been looking at dividend growth shares for ...

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due to a ...

Mark David Hartley considers how investors could build towards an early retirement plan with a second income from a portfolio ...

Babcock International's flying after upgrading its full-year forecasts. I think the FTSE 250 defence share might just be ...

Barclays shares have vastly outperformed the market over the past 12 months, but it’s a different story over the longer run.

A big step up in AI spending at Google has investors nervous, but has it created an opportunity to buy its shares at an ...

I think BAE Systems’ share price is down on the false assumption that the global security threat will fall in the coming ...

JD Sports has had a disastrous few months of losses but 2025 looks primed to be the year for this FTSE 100 fashion icon to ...

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's ...

These small-cap stocks have enjoyed strong price gains since New Year's Day. Royston Wild reckons they could keep on climbing ...

Warren Buffett is the most successful investor at least in terms of net wealth. So, what is his favourite stock and should ...